Zydus Lifesciences consolidated net profit rises 30.64% in the June 2024 quarter
Net profit of Zydus Lifesciences rose 30.64% to Rs 1419.90 crore in the quarter ended June 2024 as against Rs 1086.90 crore during the previous quarter ended June 2023. Sales rose 19.67% to Rs 6046.50 crore in the quarter ended June 2024 as against Rs 5052.80 crore during the previous quarter ended June 2023.
Particulars | Quarter Ended | ||
Jun. 2024 | Jun. 2023 | % Var. | |
Sales | 6046.50 | 5052.80 | 20 |
OPM % | 34.47 | 29.79 | - |
PBDT | 2115.00 | 1523.20 | 39 |
PBT | 1899.70 | 1343.40 | 41 |
NP | 1419.90 | 1086.90 | 31 |
Low Price Shares
0 mins read . Dec 18, 2024
Nifty 50 Top 10 Stocks
0 mins read . Dec 18, 2024
Best Stocks in 2025
0 mins read . Dec 18, 2024
Explore our products
₹0 Brokerage *
Open Demat Account